Filing Details
- Accession Number:
- 0001562180-20-006646
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-10 16:53:46
- Reporting Period:
- 2020-11-06
- Accepted Time:
- 2020-11-10 16:53:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 842023 | Bio-Techne Corp | TECH | Biological Products, (No Disgnostic Substances) (2836) | 411427402 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1208906 | L John Higgins | 11085 North Torrey Pines Road Suite 300 La Jolla CA 92037 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-11-06 | 5,000 | $70.35 | 9,412 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-06 | 1,450 | $298.98 | 7,962 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-06 | 450 | $299.84 | 7,512 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-06 | 3,100 | $301.06 | 4,412 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-11-06 | 5,000 | $0.00 | 5,000 | $70.35 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2011-10-27 | 2021-10-26 | No | 4 | M | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | $201.64 | 2020-10-24 | 2029-10-24 | 2,011 | 2,011 | Direct |
| Common Stock | Stock Option (Right to Buy) | $179.84 | 2019-10-24 | 2028-10-25 | 1,898 | 1,898 | Direct |
| Common Stock | Stock Options (Right to buy) | $125.05 | 2018-10-25 | 2027-10-27 | 3,125 | 3,125 | Direct |
| Common Stock | Stock Option (Right to Buy) | $101.19 | 2017-10-26 | 2026-10-26 | 3,985 | 3,985 | Direct |
| Common Stock | Stock Option (Right to Buy) | $87.34 | 2016-10-29 | 2025-10-28 | 4,260 | 4,260 | Direct |
| Common Stock | Stock Option (Right to Buy) | $91.78 | 2014-10-30 | 2024-10-30 | 4,000 | 4,000 | Direct |
| Common Stock | Stock Option (Right to Buy) | $87.39 | 2013-10-31 | 2023-10-30 | 4,000 | 4,000 | Direct |
| Common Stock | Stock Option (Right to Buy) | $66.90 | 2012-10-25 | 2022-10-24 | 5,000 | 5,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2029-10-24 | 2,011 | 2,011 | Direct |
| 2028-10-25 | 1,898 | 1,898 | Direct |
| 2027-10-27 | 3,125 | 3,125 | Direct |
| 2026-10-26 | 3,985 | 3,985 | Direct |
| 2025-10-28 | 4,260 | 4,260 | Direct |
| 2024-10-30 | 4,000 | 4,000 | Direct |
| 2023-10-30 | 4,000 | 4,000 | Direct |
| 2022-10-24 | 5,000 | 5,000 | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $298.5100 to $299.2800, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $299.6050 to $300.4491, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $300.9950 to $301.0647, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
